LB-010 Safety and effectiveness assessment of the surpass evolve (SEASE): a real-world international multicenter study
Recommended Citation
Yoo A, Geyik S, Froehler M, et al. E-250 eTICI 2b67–3 is an optimal reperfusion benchmark and is achieved on the first pass in two out of every three cases in the NeVa clear study. Journal of NeuroInterventional Surgery. 2023;15(Suppl 1):A227-A228. doi:10.1136/jnis-2023-SNIS.349
Document Type
Abstract
